-
1
-
-
0024556687
-
Reduced bone mass in daughters of women with osteoporosis
-
Seeman E., Hopper J.L., Bach L.A., et al. Reduced bone mass in daughters of women with osteoporosis. New Engl. J. Med. 320:1989;554-558.
-
(1989)
New Engl. J. Med.
, vol.320
, pp. 554-558
-
-
Seeman, E.1
Hopper, J.L.2
Bach, L.A.3
-
2
-
-
0025812532
-
Genetic determinants of bone mass in adult women: A revaluation of the twin model and of the potential importance of gene interaction on heritability estimates
-
Slemenda C.W., Christian J.C., Williams C.J., Norton J.A., Johnston C.C. Jr. Genetic determinants of bone mass in adult women: a revaluation of the twin model and of the potential importance of gene interaction on heritability estimates. J. Bone Miner. Res. 6:1991;561-567.
-
(1991)
J. Bone Miner. Res.
, vol.6
, pp. 561-567
-
-
Slemenda, C.W.1
Christian, J.C.2
Williams, C.J.3
Norton, J.A.4
Johnston Jr., C.C.5
-
3
-
-
0025862957
-
Genetic factors in bone turnover
-
Kelly P.J., Hopper J.L., Macaskill G.T., Pocock N.A., Sambrook P.N., Eisman J.A. Genetic factors in bone turnover. J. Clin. Endocrinol. Metab. 72:1991;808-813.
-
(1991)
J. Clin. Endocrinol. Metab.
, vol.72
, pp. 808-813
-
-
Kelly, P.J.1
Hopper, J.L.2
MacAskill, G.T.3
Pocock, N.A.4
Sambrook, P.N.5
Eisman, J.A.6
-
4
-
-
0019208916
-
Decreased risk of fractures of the hip and lower forearm with postmenopausal use of oestrogen
-
Weiss N.S., Ure C.L., Ballard J.H., Williams A.R., Daling J.R. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of oestrogen. New Engl. J. Med. 0303:1980;1195-1198.
-
(1980)
New Engl. J. Med.
, vol.303
, pp. 1195-1198
-
-
Weiss, N.S.1
Ure, C.L.2
Ballard, J.H.3
Williams, A.R.4
Daling, J.R.5
-
5
-
-
0023229530
-
Hip fracture and the use of estrogens in postmenopausal women. The Framingham study
-
Kiel D.P., Felson D.T., Anderson J.J., Wilson P.W., Moskowitz M.A. Hip fracture and the use of estrogens in postmenopausal women. The Framingham study. New Engl. J. Med. 317:1987;1169-1174.
-
(1987)
New Engl. J. Med.
, vol.317
, pp. 1169-1174
-
-
Kiel, D.P.1
Felson, D.T.2
Anderson, J.J.3
Wilson, P.W.4
Moskowitz, M.A.5
-
7
-
-
0021271265
-
The minimum effective dose of oestrogen for prevention of postmenopausal bone loss
-
Lindsay R., Hart D.M., Clark D.M. The minimum effective dose of oestrogen for prevention of postmenopausal bone loss. Obstet. Gynecol. 63:(6):1984;759-763.
-
(1984)
Obstet. Gynecol.
, vol.63
, Issue.6
, pp. 759-763
-
-
Lindsay, R.1
Hart, D.M.2
Clark, D.M.3
-
8
-
-
84919592252
-
Long-term prevention of postmenopausal osteoporosis by oestrogen
-
Lindsay R., Hart D.M., Aitken J.M., MacDonald E.B., Anderson J.B., Clarke A.C. Long-term prevention of postmenopausal osteoporosis by oestrogen. Lancet. 1:(7968):1976;1038-1040.
-
(1976)
Lancet
, vol.1
, Issue.7968
, pp. 1038-1040
-
-
Lindsay, R.1
Hart, D.M.2
Aitken, J.M.3
MacDonald, E.B.4
Anderson, J.B.5
Clarke, A.C.6
-
9
-
-
0024997302
-
17-β. Estradiol and continuous norethisterone: A unique treatment of established osteoporosis in elderly women
-
Christiansen C., Riis B.J. 17-β. Estradiol and continuous norethisterone: a unique treatment of established osteoporosis in elderly women. J. Clin. Enocrinol. Metab. 71:1990;836-841.
-
(1990)
J. Clin. Enocrinol. Metab.
, vol.71
, pp. 836-841
-
-
Christiansen, C.1
Riis, B.J.2
-
10
-
-
0033783084
-
Changes in LDL density across the menopausal transition
-
Carr M.C., Kim K.H., Zambon A., et al. Changes in LDL density across the menopausal transition. J. Invest. Med. 48:(4):2000;245-250.
-
(2000)
J. Invest. Med.
, vol.48
, Issue.4
, pp. 245-250
-
-
Carr, M.C.1
Kim, K.H.2
Zambon, A.3
-
11
-
-
0026234752
-
Extraskeletal effects of oestrogen and the prevention of atherosclerosis
-
Bush T.L. Extraskeletal effects of oestrogen and the prevention of atherosclerosis. Osteporosis Int. 2:1991;5-11.
-
(1991)
Osteporosis Int.
, vol.2
, pp. 5-11
-
-
Bush, T.L.1
-
12
-
-
0032552636
-
Hormone replacement therapy in postmenopausal women with specific risk factors for coronary artery disease
-
Van der Mooren M.J., Mijatovic V., Van Baal W.M., Stehouwer C.D. Hormone replacement therapy in postmenopausal women with specific risk factors for coronary artery disease. Maturitas. 30:1998;27-36.
-
(1998)
Maturitas
, vol.30
, pp. 27-36
-
-
Van Der Mooren, M.J.1
Mijatovic, V.2
Van Baal, W.M.3
Stehouwer, C.D.4
-
13
-
-
0025940856
-
Postmenopausal oestrogen therapy in cardiovascular disease: Ten year follow-up from the nurses' health study
-
Stampfer M.J., Colditz G.A., Willett W.C., et al. Postmenopausal oestrogen therapy in cardiovascular disease: ten year follow-up from the nurses' health study. New Engl. J. Med. 325:1991;756-762.
-
(1991)
New Engl. J. Med.
, vol.325
, pp. 756-762
-
-
Stampfer, M.J.1
Colditz, G.A.2
Willett, W.C.3
-
14
-
-
0032547326
-
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
-
Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. J. Am. Med. Assoc. 280:1998;605-613.
-
(1998)
J. Am. Med. Assoc.
, vol.280
, pp. 605-613
-
-
Hulley, S.1
Grady, D.2
Bush, T.3
-
15
-
-
0034710627
-
Effects of estrogen replacement on the progression of coronary-artery atherosclerosis
-
Herrington D.M., Reboussin D.M., Broshnihan K.B., et al. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. New Engl. J. Med. 343:2000;522-529.
-
(2000)
New Engl. J. Med.
, vol.343
, pp. 522-529
-
-
Herrington, D.M.1
Reboussin, D.M.2
Broshnihan, K.B.3
-
16
-
-
0036898962
-
Perspectives on the women's health initiative trial of hormone replacement therapy
-
Grimes D.A., Lobo R.A. Perspectives on the women's health initiative trial of hormone replacement therapy. Obstet. Gynecol. 100:2002;1344-1353.
-
(2002)
Obstet. Gynecol.
, vol.100
, pp. 1344-1353
-
-
Grimes, D.A.1
Lobo, R.A.2
-
17
-
-
0037125379
-
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women's health initiative randomised controlled trial
-
Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomised controlled trial. J. Am. Med. Assoc. 288:2002;321-333.
-
(2002)
J. Am. Med. Assoc.
, vol.288
, pp. 321-333
-
-
Rossouw, J.E.1
Anderson, G.L.2
Prentice, R.L.3
-
18
-
-
0034122281
-
Three year study of oestrogen alone versus combined with progestin in postmenopausal women with or without hypercholesterolemia
-
Sanada M., Nakagawa H., Kodoma I., Sakasita T., Ohama K. Three year study of oestrogen alone versus combined with progestin in postmenopausal women with or without hypercholesterolemia. Metabolism. 49:(6):2000;784-789.
-
(2000)
Metabolism
, vol.49
, Issue.6
, pp. 784-789
-
-
Sanada, M.1
Nakagawa, H.2
Kodoma, I.3
Sakasita, T.4
Ohama, K.5
-
19
-
-
0033829776
-
Low doses of estradiol in combination with gestodene to prevent early postmenopausal bone loss
-
Bjarnason N.H., Byrjalsen I., Hassager C., Haarbo J., Christiansen C. Low doses of estradiol in combination with gestodene to prevent early postmenopausal bone loss. Am. J. Obstet. Gynecol. 183:2000;550-560.
-
(2000)
Am. J. Obstet. Gynecol.
, vol.183
, pp. 550-560
-
-
Bjarnason, N.H.1
Byrjalsen, I.2
Hassager, C.3
Haarbo, J.4
Christiansen, C.5
-
20
-
-
0025752582
-
Serum lipids, lipoproteins and apolipoproteins during postmenopausal oestrogen replacement therapy combined with either 19-nortestosterone derivates or 17-hydroxyprogesterone derivates
-
Haarbo J., Hassager C., Jensen S.B., Riis B.J., Christiansen C. Serum lipids, lipoproteins and apolipoproteins during postmenopausal oestrogen replacement therapy combined with either 19-nortestosterone derivates or 17-hydroxyprogesterone derivates. Am. J. Med. 90:1991;584-589.
-
(1991)
Am. J. Med.
, vol.90
, pp. 584-589
-
-
Haarbo, J.1
Hassager, C.2
Jensen, S.B.3
Riis, B.J.4
Christiansen, C.5
-
21
-
-
0034065195
-
Early response in biochemical markers predicts long-term response in bone mass during hormone replacement therapy in early postmenopausal women
-
Bjarnason N.H., Christiansen C. Early response in biochemical markers predicts long-term response in bone mass during hormone replacement therapy in early postmenopausal women. Bone. 26:(6):2000;561-569.
-
(2000)
Bone
, vol.26
, Issue.6
, pp. 561-569
-
-
Bjarnason, N.H.1
Christiansen, C.2
-
22
-
-
0030890138
-
Sex steroids and the cardiovascular system
-
Christiansen C. Sex steroids and the cardiovascular system. Osteoporosis Int. 7:(Suppl. 1):1997;S8-11.
-
(1997)
Osteoporosis Int.
, vol.7
, Issue.SUPPL. 1
, pp. 8-11
-
-
Christiansen, C.1
-
23
-
-
0030846737
-
Association of bone mineral density with apolipoprotein e phenotype
-
Shiraki M., Shiraki Y., Aoki C., et al. Association of bone mineral density with apolipoprotein E phenotype. J. Bone Miner. Res. 12:(9):1997;1438-1445.
-
(1997)
J. Bone Miner. Res.
, vol.12
, Issue.9
, pp. 1438-1445
-
-
Shiraki, M.1
Shiraki, Y.2
Aoki, C.3
-
24
-
-
0035131143
-
Estrogens, lipids and cardiovascular disease: No easy answers
-
Bittner V. Estrogens, lipids and cardiovascular disease: no easy answers. JACC. 37:(2):2001;431-433.
-
(2001)
JACC
, vol.37
, Issue.2
, pp. 431-433
-
-
Bittner, V.1
-
25
-
-
0034650274
-
Does apolipoprotein e genotype relate to BMD and bone markers in postmenopausal women
-
Heikkinen A.M., Kroger H., Niskanen L., et al. Does apolipoprotein E genotype relate to BMD and bone markers in postmenopausal women. Maturitas. 34:(1):2000;33-41.
-
(2000)
Maturitas
, vol.34
, Issue.1
, pp. 33-41
-
-
Heikkinen, A.M.1
Kroger, H.2
Niskanen, L.3
-
26
-
-
0035158822
-
Atherogenic high-fat diet reduces bone mineralization in mice
-
Parhami F., Tintut Y., Beamer W.G., Gharavi N., Goodman W., Demer L. Atherogenic high-fat diet reduces bone mineralization in mice. J. Bone Miner. Res. 16:2001;182-188.
-
(2001)
J. Bone Miner. Res.
, vol.16
, pp. 182-188
-
-
Parhami, F.1
Tintut, Y.2
Beamer, W.G.3
Gharavi, N.4
Goodman, W.5
Demer, L.6
-
27
-
-
0033521078
-
Stimulation of bone formation in vitro and in rodents by statins
-
Mundy G., Garret R., Harris S., et al. Stimulation of bone formation in vitro and in rodents by statins. Science. 286:1999;1946-1949.
-
(1999)
Science
, vol.286
, pp. 1946-1949
-
-
Mundy, G.1
Garret, R.2
Harris, S.3
-
28
-
-
0034709764
-
Oral statin and increase in bone mineral density in postmenopausal women
-
Edwards C.J., Hart D.J., Spector T.D. Oral statin and increase in bone mineral density in postmenopausal women. Lancet. 355:2000;2218-2219.
-
(2000)
Lancet
, vol.355
, pp. 2218-2219
-
-
Edwards, C.J.1
Hart, D.J.2
Spector, T.D.3
-
29
-
-
0031977199
-
Nitrogen-containing biphosphonates inhibit the mevalonate pathway and prevent post-translocational prenylation of GTP-binding proteins, including RAS
-
Luckman S.P., Hughes D.E., Coxon F.P., Graham R., Russel G., Rogers M.J. Nitrogen-containing biphosphonates inhibit the mevalonate pathway and prevent post-translocational prenylation of GTP-binding proteins, including RAS. J. Bone Miner. Res. 13:1998;581-589.
-
(1998)
J. Bone Miner. Res.
, vol.13
, pp. 581-589
-
-
Luckman, S.P.1
Hughes, D.E.2
Coxon, F.P.3
Graham, R.4
Russel, G.5
Rogers, M.J.6
-
31
-
-
0000128416
-
Does statin reduce risk of fracture in postmenopausal women? Results from the women's health initiative observational study (WHI-OS)
-
La Croix A.Z., Cauley J.S., Jackson R., et al. Does statin reduce risk of fracture in postmenopausal women? Results from the women's health initiative observational study (WHI-OS). J. Bone Miner. Res. 15:(Suppl. 1):2000;S155.
-
(2000)
J. Bone Miner. Res.
, vol.15
, Issue.SUPPL. 1
, pp. 155
-
-
La Croix, A.Z.1
Cauley, J.S.2
Jackson, R.3
-
32
-
-
0035901052
-
Effect of pravastatin on frequency of fracture in the LIPID study: Secondary analysis of a randomised controlled trial
-
Reid I.R., Hague W., Emberson J., et al. Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Lancet. 357:2001;509-512.
-
(2001)
Lancet
, vol.357
, pp. 509-512
-
-
Reid, I.R.1
Hague, W.2
Emberson, J.3
-
33
-
-
0037170846
-
Estrogen receptor alpha ploymorphism as a genetic marker for bone loss, vertebral fractures and susceptibility to estrogen
-
Kobayashi N., Fujino T., Shirogane T., et al. Estrogen receptor alpha ploymorphism as a genetic marker for bone loss, vertebral fractures and susceptibility to estrogen. Maturitas. 41:2002;193-201.
-
(2002)
Maturitas
, vol.41
, pp. 193-201
-
-
Kobayashi, N.1
Fujino, T.2
Shirogane, T.3
|